大葉大學圖書館 |

Perspectives in translational research in life sciences and biomedicine[electronic resource] :translational outcomes research in life sciences and translational medicine.Volume 1 /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	507.2
書名/作者:	Perspectives in translational research in life sciences and biomedicine : translational outcomes research in life sciences and translational medicine./ by Ena Ray Banerjee.
作者:	Banerjee, Ena Ray.
出版者:	Singapore : : Springer Singapore :, 2016.
面頁冊數:	xii, 270 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Life sciences - Research.
標題:	Medicine - Research.
標題:	Life Sciences.
標題:	Regenerative Medicine/Tissue Engineering.
標題:	Molecular Medicine.
標題:	Gene Therapy.
標題:	Antibodies.
標題:	Animal Models.
ISBN:	9789811009891
ISBN:	9789811009884
內容註:	Chapter 1. Translational Research in Life Sciences -- Chapter 2. Preclinical disease models as a platform for drug discovery -- Chapter 3. Novel antibodies as a replacement for antibiotics -- Chapter 4. Functional Food and Nutraceuticals -- Chapter 5. Bio-Green-Technology as a multi-disciplinary interface amongst the Life Sciences.
摘要、提要註:	The present book addresses the multi-disciplinary nature of Translational Outcomes Research, which is a watershed for nearly all the disciplines of Life and Health Sciences, along with the Materials Sciences including but not limited to Zoology, Botany, Microbiology, Biochemistry, Physiology, Nanotechnology, the Medical Sciences, Bioengineering, Biophysics, Medicinal Chemistry, Structural Biology, Biostatistics and Bioinformatics. This book, for the first time, addresses the basic premises of fundamental research in facilitating drug discovery. One chapter is dedicated to a novel generation of platforms with novel camelid antibodies and their technological extensions, while another focuses on functional food and nutraceuticals. The book begins with a thorough overview of what translational outcomes research connotes and what the current status of research in the area is, and goes on to elucidate various pertinent preclinical disease models and their uses in basic and application based research in the Life Sciences. How basic approaches to screening and characterization vis-a-vis their role in amelioration of the two cardinal problems of inflammation and degeneration involved in most diseases is elucidated. The book ends with a discussion of the relevance and importance of using Bio Green technology in Translational Outcomes, addressing the need to fill the gap between academia and industry and clinics that can arise through direct or indirect collaboration between the stakeholders and emphasizing the need for an eco-friendly approach so as not to jeopardize the fine balance that holds life on earth in harmony.
電子資源:	http://dx.doi.org/10.1007/978-981-10-0989-1

Perspectives in translational research in life sciences and biomedicine[electronic resource] :translational outcomes research in life sciences and translational medicine.Volume 1 /
Banerjee, Ena Ray.

Perspectives in translational research in life sciences and biomedicinetranslational outcomes research in life sciences and translational medicine.Volume 1 /[electronic resource] :by Ena Ray Banerjee. - Singapore :Springer Singapore :2016. - xii, 270 p. :ill., digital ;24 cm.

Chapter 1. Translational Research in Life Sciences -- Chapter 2. Preclinical disease models as a platform for drug discovery -- Chapter 3. Novel antibodies as a replacement for antibiotics -- Chapter 4. Functional Food and Nutraceuticals -- Chapter 5. Bio-Green-Technology as a multi-disciplinary interface amongst the Life Sciences.

The present book addresses the multi-disciplinary nature of Translational Outcomes Research, which is a watershed for nearly all the disciplines of Life and Health Sciences, along with the Materials Sciences including but not limited to Zoology, Botany, Microbiology, Biochemistry, Physiology, Nanotechnology, the Medical Sciences, Bioengineering, Biophysics, Medicinal Chemistry, Structural Biology, Biostatistics and Bioinformatics. This book, for the first time, addresses the basic premises of fundamental research in facilitating drug discovery. One chapter is dedicated to a novel generation of platforms with novel camelid antibodies and their technological extensions, while another focuses on functional food and nutraceuticals. The book begins with a thorough overview of what translational outcomes research connotes and what the current status of research in the area is, and goes on to elucidate various pertinent preclinical disease models and their uses in basic and application based research in the Life Sciences. How basic approaches to screening and characterization vis-a-vis their role in amelioration of the two cardinal problems of inflammation and degeneration involved in most diseases is elucidated. The book ends with a discussion of the relevance and importance of using Bio Green technology in Translational Outcomes, addressing the need to fill the gap between academia and industry and clinics that can arise through direct or indirect collaboration between the stakeholders and emphasizing the need for an eco-friendly approach so as not to jeopardize the fine balance that holds life on earth in harmony.

ISBN: 9789811009891

Standard No.: 10.1007/978-981-10-0989-1doiSubjects--Topical Terms:

576976
Life sciences
--Research.

LC Class. No.: QH315 / .B36 2016

Dewey Class. No.: 507.2

Perspectives in translational research in life sciences and biomedicine[electronic resource] :translational outcomes research in life sciences and translational medicine.Volume 1 /
LDR:03027nam a2200313 a 4500 001 450362
003 DE-He213
005 20161019153613.0
006 m d
007 cr nn 008maaau
008 161210s2016 si s 0 eng d
020 $a 9789811009891 $q (electronic bk.)
020 $a 9789811009884 $q (paper)
024 7 $a 10.1007/978-981-10-0989-1 $2 doi
035 $a 978-981-10-0989-1
040 $a GP $c GP
041 0 $a eng
050 4 $a QH315 $b .B36 2016
072 7 $a PSF $2 bicssc
072 7 $a SCI049000 $2 bisacsh
082 0 4 $a 507.2 $2 23
090 $a QH315 $b .B215 2016
100 1 $a Banerjee, Ena Ray. $3 611664
245 1 0 $a Perspectives in translational research in life sciences and biomedicine $h [electronic resource] : $b translational outcomes research in life sciences and translational medicine. $n Volume 1 / $c by Ena Ray Banerjee.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2016.
300 $a xii, 270 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Translational Research in Life Sciences -- Chapter 2. Preclinical disease models as a platform for drug discovery -- Chapter 3. Novel antibodies as a replacement for antibiotics -- Chapter 4. Functional Food and Nutraceuticals -- Chapter 5. Bio-Green-Technology as a multi-disciplinary interface amongst the Life Sciences.
520 $a The present book addresses the multi-disciplinary nature of Translational Outcomes Research, which is a watershed for nearly all the disciplines of Life and Health Sciences, along with the Materials Sciences including but not limited to Zoology, Botany, Microbiology, Biochemistry, Physiology, Nanotechnology, the Medical Sciences, Bioengineering, Biophysics, Medicinal Chemistry, Structural Biology, Biostatistics and Bioinformatics. This book, for the first time, addresses the basic premises of fundamental research in facilitating drug discovery. One chapter is dedicated to a novel generation of platforms with novel camelid antibodies and their technological extensions, while another focuses on functional food and nutraceuticals. The book begins with a thorough overview of what translational outcomes research connotes and what the current status of research in the area is, and goes on to elucidate various pertinent preclinical disease models and their uses in basic and application based research in the Life Sciences. How basic approaches to screening and characterization vis-a-vis their role in amelioration of the two cardinal problems of inflammation and degeneration involved in most diseases is elucidated. The book ends with a discussion of the relevance and importance of using Bio Green technology in Translational Outcomes, addressing the need to fill the gap between academia and industry and clinics that can arise through direct or indirect collaboration between the stakeholders and emphasizing the need for an eco-friendly approach so as not to jeopardize the fine balance that holds life on earth in harmony.
650 0 $a Life sciences $x Research. $3 576976
650 0 $a Medicine $x Research. $3 341824
650 1 4 $a Life Sciences. $3 463509
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 588523
650 2 4 $a Molecular Medicine. $3 463625
650 2 4 $a Gene Therapy. $3 336987
650 2 4 $a Antibodies. $3 465154
650 2 4 $a Animal Models. $3 603684
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-0989-1
950 $a Biomedical and Life Sciences (Springer-11642)